• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Securities
Issues & Trends

[Exclusive] Aegis and Blue Cove Clash Head-on Over Selection Criteria for Preferred Partner for Timework Myeongdong

Amid controversy over the fairness of the sale process for “Timework Myeongdong,” valued at 500 billion won, a tense standoff has emerged between Aegis Asset Management’s assertion of “transaction sta…
  • 2026-08-20 18:14:05
  • JI YEONG-EUI
Issues & Trends

GFC Life Science Co., Ltd. Signs Exclusive Supply Agreements with Vietnam and Italy… Expands Global Reach

GFC Life Science(388610)announced on the 20th that its in-house derma-cosmetic brand “fmk” has signed exclusive supply agreements with local distributors in Vietnam and Italy.Launched last March, fmk …
  • 2026-08-20 15:27:09
  • Shin Ha-yeon
Issues & Trends

"We Need to Average Down Quickly"... Tesla Takes the Hit Instead of Samsung Electronics

Mr. Kim (28), an office worker and “Seohak Gaemi” (a retail investor who invests in foreign stocks), recently found himself in a sweat-inducing situation while trying to trade a Tesla 2x leveraged exc…
  • 2026-08-20 15:25:14
  • Kim Kyung-eun
Disclosure Plus

XIIlab Co., Ltd Signs 2.8 Billion Supply Contract for NVIDIA AI Products

AI solutions company XIIlab Co., Ltd(189330)has signed a supply contract with NVIDIA for the DGX Rubin NVL8, NVIDIA’s AI computing system, and NVIDIA AI Enterprise, a software platform that supports A…
  • 2026-08-20 13:55:59
  • Kim Hyung-il
Disclosure Plus

Hantop Inc. Conducts 3.2 Billion Won Third-Party Private Placement for Seokjeong Industry… Raising Working Capital

Hantop Inc. ( Hantop Inc.(002680)), which operates in the flour milling and animal feed industries, is conducting a third-party private placement worth 3.2 billion won targeting Seokjeong Industry, an…
  • 2026-08-20 12:53:44
  • Kim Hyung-il
Issues & Trends

[Market In] MBK: “KoreaZinc Included False Information in AGM Materials”… Threatens to File Criminal Complaint

Ahead of the extraordinary general meeting of shareholders scheduled for September 9, MBK Partners pointed out that the explanatory materials on the agenda distributed by KoreaZinc(010130)“contain fal…
  • 2026-08-20 10:49:01
  • Hur Jieun
Issues & Trends

LaonPeople Inc. Reports 160% Year-Over-Year Increase in First-Half Golf Sales… “On a High-Growth Trajectory”

AI specialist LaonPeople Inc.(300120)announced on the 20th that it recorded approximately 3 billion won in sales in its golf sensor division during the first half of this year. The company achieved 1.…
  • 2026-08-20 09:52:37
  • Park Jung-Soo
Stocks in Focus

Alteogen Inc.: 'Keytruda SC' Draws Attention Following Moderna and Merck’s Successful 'mRNA Cancer Vaccine Phase 3 Trial' [Featured Stocks]

Alteogen Inc.(196170)is trading higher in early trading on the 20th as the value of “Keytruda SC” is drawing attention following the successful Phase 3 clinical trials of mRNA cancer vaccines by globa…
  • 2026-08-20 09:39:05
  • PARK MIN
Stocks in Focus

FutureChem Co., Ltd. Rises Over 4% on First Sales of New Prostate Cancer Diagnostic Drug [Featured Stock]

FutureChem Co., Ltd.(220100)is trading higher in early trading following news that it has generated revenue from the first sales of “Prostavue Injection,” Korea’s first new drug for prostate cancer di…
  • 2026-08-20 09:35:48
  • Shin Ha-yeon
Stocks in Focus

Moderna Soars 177%, Sparking a Rally in mRNA Stocks… NIBEC CO., LTD. Hits Daily Limit Up [Featured Stocks]

Domestic mRNA-related stocks are trading higher in early trading following news that a personalized messenger ribonucleic acid (mRNA) cancer treatment jointly developed by Moderna and Merck has achiev…
  • 2026-08-20 09:28:41
  • Shin Ha-yeon
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English